Market revenue in 2023 | USD 26.2 million |
Market revenue in 2030 | USD 65.9 million |
Growth rate | 14.1% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 25.19% in 2023. Horizon Databook has segmented the Spain research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is witnessing a substantial increase in biopharmaceutical R&D activities due to rising scientific awareness and growing investments in the healthcare sector. R&D investments in the pharmaceutical industry in the country reached USD 1382 million (EUR 1,267 million) in 2021, recording an increase of 9.2% over the previous year.
Amid the growing research sector in the country, several emerging players are undertaking expansion activities to further broaden their market presence. For instance, in February 2023, Spanish CDMO 53Biologics expanded its manufacturing facilities in the Boecillo Technology Park, Spain, to meet the increasing demand in the country.
In addition, the country’s government is boosting innovation & local drug production through tax incentives and preferential treatment for local players to reinforce its position as a clinical trial destination. These factors are likely to accelerate the growth of the research-grade proteins market in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Spain research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account